References
- Li M, Wang L, Li S. Survey on bacterial resistance and antibiotics usage among paediatrics. (Abstract in English). Chinese Journal of Public Health 2007;23:650–1.
- Yu JL, Wu SX, Jia HQ. Study on antimicrobial susceptibility of bacteria causing neonatal infections: a 12 year study (1987–1998). Singapore Med J 2001;42:107–10.
- Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 1998;11:589–603.
- Thaver D, Ali SA, Zaidi AK. Antimicrobial resistance among neonatal pathogens in developing countries. Pediatr Infect Dis J 2009;28:S19–21.
- Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. CLSI/NCCLS M100–S19. Wayne, PA: CLSI; 2009.
- Tullus K, Berglund B, Fryklund B, Kühn I, Burman LG. Epidemiology of fecal strains of the family Enterobacteriaceae in 22 neonatal wards and influence of antibiotic policy. J Clin Microbiol 1998;26:1166–70.
- Mendes C, Kiffer C, Segura A, Ribeiro J, Turner P. Klebsiella pneumoniae with multiple antimicrobial resistance. Braz J Infect Dis 2004;8:109–11.
- Chen YH, Hsueh PR, Badal RE, Hawser SP, Hoban DJ, Bouchillon SK, et al. Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria. J Infect 2011;62:280–91.
- Corkill JE, Cuevas LE, Gurgel RQ, Greensill J, Hart CA. SHV-27, a novel cefotaxime-hydrolysing β-lactamase, identified in Klebsiella pneumoniae isolates from a Brazilian hospital. J Antimicrob Chemother 2001;47:463–5.
- Hoban DJ, Bouchillon SK, Hawser SP, Badal RE, Labombardi VJ, DiPersio J. Susceptibility of Gram-negative pathogens isolated from patients with complicated intra- abdominal infections in the United States, 2007–2008: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART). Antimicrob Agents Chemother 2010; 54:3031–4.
- Yan JJ, Wu SM, Tsai SH, Wu JJ, Su IJ. Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum β-lactamase and identification of a novel AmpC enzyme (CMY-8) in southern Taiwan. Antimicrob Agents Chemother 2000;44:1438–42.
- Hansen DS, Schumacher H, Hansen F, Stegger M, Hertz FB, Schønning K, et al. Extended-spectrum β-lactamase (ESBL) in Danish clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence, β-lactamase distribution, phylogroups, and co-resistance. Scand J Infect Dis 2012;44: 174–81.
- Quale JM, Landman D, Bradford PA, Visalli M, Ravishankar J, Flores C, et al. Molecular epidemiology of a citywide outbreak of extended spectrum β-lactamase producing Klebsiella pneumoniae infection. Clin Infect Dis 2002;35:834–41.
- Pena C, Pujol M, Ardanuy C, Ricart A, Pallarés R, Liñares J, et al. An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum β-lactamase. J Hosp Infect 2001;47: 53–9.
- Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001;14: 933–51.